Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 1263

1.

Misclassification of first-line antiretroviral treatment failure based on immunological monitoring of HIV infection in resource-limited settings.

Kantor R, Diero L, Delong A, Kamle L, Muyonga S, Mambo F, Walumbe E, Emonyi W, Chan P, Carter EJ, Hogan J, Buziba N.

Clin Infect Dis. 2009 Aug 1;49(3):454-62. doi: 10.1086/600396.

PMID:
19569972
[PubMed - indexed for MEDLINE]
Free Article
2.

Diagnosis of antiretroviral therapy failure in Malawi: poor performance of clinical and immunological WHO criteria.

van Oosterhout JJ, Brown L, Weigel R, Kumwenda JJ, Mzinganjira D, Saukila N, Mhango B, Hartung T, Phiri S, Hosseinipour MC.

Trop Med Int Health. 2009 Aug;14(8):856-61. doi: 10.1111/j.1365-3156.2009.02309.x. Epub 2009 Jun 22.

PMID:
19552661
[PubMed - indexed for MEDLINE]
Free Article
3.

Treatment failure and mortality factors in patients receiving second-line HIV therapy in resource-limited countries.

Pujades-Rodríguez M, Balkan S, Arnould L, Brinkhof MA, Calmy A; AIDS Working Group of MSF.

JAMA. 2010 Jul 21;304(3):303-12. doi: 10.1001/jama.2010.980.

PMID:
20639564
[PubMed - indexed for MEDLINE]
4.

Lability of antiretroviral drug resistance mutations--correlates with immunological and virological responses.

Al Mazari A, Zomaya AY, Charleston M, Salem H, Maher A, Garsia RJ.

Curr HIV Res. 2007 Jul;5(4):430-9.

PMID:
17627506
[PubMed - indexed for MEDLINE]
5.

Outcomes from monitoring of patients on antiretroviral therapy in resource-limited settings with viral load, CD4 cell count, or clinical observation alone: a computer simulation model.

Phillips AN, Pillay D, Miners AH, Bennett DE, Gilks CF, Lundgren JD.

Lancet. 2008 Apr 26;371(9622):1443-51. doi: 10.1016/S0140-6736(08)60624-8.

PMID:
18440426
[PubMed - indexed for MEDLINE]
6.

Resistance profiles after different periods of exposure to a first-line antiretroviral regimen in a Cameroonian cohort of HIV type-1-infected patients.

Soria A, Porten K, Fampou-Toundji JC, Galli L, Mougnutou R, Buard V, Kfutwah A, Vessière A, Rousset D, Teck R, Calmy A, Ciaffi L, Lazzarin A, Gianotti N.

Antivir Ther. 2009;14(3):339-47.

PMID:
19474468
[PubMed - indexed for MEDLINE]
7.

Predictors of virological outcome and safety in primary HIV type 1-infected patients initiating quadruple antiretroviral therapy: QUEST GW PROB3005.

Hoen B, Cooper DA, Lampe FC, Perrin L, Clumeck N, Phillips AN, Goh LE, Lindback S, Sereni D, Gazzard B, Montaner J, Stellbrink HJ, Lazzarin A, Ponscarme D, Staszewski S, Mathiesen L, Smith D, Finlayson R, Weber R, Wegmann L, Janossy G, Kinloch-de Loes S; QUEST Study Group.

Clin Infect Dis. 2007 Aug 1;45(3):381-90. Epub 2007 Jun 26.

PMID:
17599319
[PubMed - indexed for MEDLINE]
Free Article
8.

Implementation of an antiretroviral access program for HIV-1-infected individuals in resource-limited settings: clinical results from 4 African countries.

Sow PS, Otieno LF, Bissagnene E, Kityo C, Bennink R, Clevenbergh P, Wit FW, Waalberg E, Rinke de Wit TF, Lange JM; Cohort Program to Evaluate Access to Antiretroviral Therapy and Education Project Team.

J Acquir Immune Defic Syndr. 2007 Mar 1;44(3):262-7.

PMID:
17146376
[PubMed - indexed for MEDLINE]
9.

Characteristics, determinants, and clinical relevance of CD4 T cell recovery to <500 cells/microL in HIV type 1-infected individuals receiving potent antiretroviral therapy.

Kaufmann GR, Furrer H, Ledergerber B, Perrin L, Opravil M, Vernazza P, Cavassini M, Bernasconi E, Rickenbach M, Hirschel B, Battegay M; Swiss HIV Cohort Study.

Clin Infect Dis. 2005 Aug 1;41(3):361-72. Epub 2005 Jun 24.

PMID:
16007534
[PubMed - indexed for MEDLINE]
Free Article
10.

Response to antiretroviral therapy in HIV-infected patients attending a public, urban clinic in Kampala, Uganda.

Spacek LA, Shihab HM, Kamya MR, Mwesigire D, Ronald A, Mayanja H, Moore RD, Bates M, Quinn TC.

Clin Infect Dis. 2006 Jan 15;42(2):252-9. Epub 2005 Dec 12.

PMID:
16355337
[PubMed - indexed for MEDLINE]
Free Article
11.

Optimal monitoring strategies for guiding when to switch first-line antiretroviral therapy regimens for treatment failure in adults and adolescents living with HIV in low-resource settings.

Chang LW, Harris J, Humphreys E.

Cochrane Database Syst Rev. 2010 Apr 14;(4):CD008494. doi: 10.1002/14651858.CD008494. Review.

PMID:
20393969
[PubMed - indexed for MEDLINE]
12.

Second-line antiretroviral therapy in resource-limited settings: the experience of Médecins Sans Frontières.

Pujades-Rodríguez M, O'Brien D, Humblet P, Calmy A.

AIDS. 2008 Jul 11;22(11):1305-12. doi: 10.1097/QAD.0b013e3282fa75b9.

PMID:
18580610
[PubMed - indexed for MEDLINE]
13.

Predictors of failure of first-line antiretroviral therapy in HIV-infected adults: Indian experience.

Rajasekaran S, Jeyaseelan L, Vijila S, Gomathi C, Raja K.

AIDS. 2007 Jul;21 Suppl 4:S47-53.

PMID:
17620752
[PubMed - indexed for MEDLINE]
14.

Discontinuation of nevirapine because of hypersensitivity reactions in patients with prior treatment experience, compared with treatment-naive patients: the ATHENA cohort study.

Wit FW, Kesselring AM, Gras L, Richter C, van der Ende ME, Brinkman K, Lange JM, de Wolf F, Reiss P.

Clin Infect Dis. 2008 Mar 15;46(6):933-40. doi: 10.1086/528861.

PMID:
18271750
[PubMed - indexed for MEDLINE]
Free Article
15.

Predictive factors for immunological and virological endpoints in Thai patients receiving combination antiretroviral treatment.

Srasuebkul P, Ungsedhapand C, Ruxrungtham K, Boyd MA, Phanuphak P, Cooper DA, Law MG.

HIV Med. 2007 Jan;8(1):46-54.

PMID:
17305932
[PubMed - indexed for MEDLINE]
16.

Monitoring for treatment failure in patients on first-line antiretroviral treatment in resource-constrained settings.

Lynen L, Van Griensven J, Elliott J.

Curr Opin HIV AIDS. 2010 Jan;5(1):1-5. doi: 10.1097/COH.0b013e3283333762. Review.

PMID:
20046141
[PubMed - indexed for MEDLINE]
17.

CD4+ T cell count recovery in HIV type 1-infected patients is independent of class of antiretroviral therapy.

Khanna N, Opravil M, Furrer H, Cavassini M, Vernazza P, Bernasconi E, Weber R, Hirschel B, Battegay M, Kaufmann GR; Swiss HIV Cohort Study.

Clin Infect Dis. 2008 Oct 15;47(8):1093-101. doi: 10.1086/592113. Erratum in: Clin Infect Dis. 2009 May 15;48(10):1491.

PMID:
18783328
[PubMed - indexed for MEDLINE]
Free Article
18.

Performance of immunologic responses in predicting viral load suppression: implications for monitoring patients in resource-limited settings.

Moore DM, Mermin J, Awor A, Yip B, Hogg RS, Montaner JS.

J Acquir Immune Defic Syndr. 2006 Dec 1;43(4):436-9.

PMID:
17019367
[PubMed - indexed for MEDLINE]
19.

Long-term immunologic and virologic responses in patients with highly resistant HIV infection who are treated with an incompletely suppressive antiretroviral regimen.

Gandhi T, Nagappan V, Cinti S, Wei W, Kazanjian P.

Clin Infect Dis. 2007 Oct 15;45(8):1085-92. Epub 2007 Sep 14.

PMID:
17879930
[PubMed - indexed for MEDLINE]
Free Article
20.

Viral load and CD4+ T lymphocyte response to highly active antiretroviral therapy in human immunodeficiency virus type 1-infected children: an observational study.

Resino S, M Bellón J, Gurbindo D, Tomás Ramos J, Antonio León J, Jose Mellado M, Angeles Muñoz-Fernández M.

Clin Infect Dis. 2003 Nov 1;37(9):1216-25. Epub 2003 Oct 3.

PMID:
14557967
[PubMed - indexed for MEDLINE]
Free Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk